Form 4: Oscar Health CFO Richard Blackley Sells Shares After Stock Unit Vesting

Oscar Health's Chief Financial Officer, Richard Blackley, sold a portion of his Class A common stock following the vesting of restricted stock units.

Summary

• Richard Blackley, the Chief Financial Officer of Oscar Health, Inc., engaged in multiple transactions involving the company's Class A common stock.
• On December 1, 2024, Mr. Blackley acquired a total of 53,245 shares through the vesting of restricted stock units.
• These vested units were from three separate grants, with 7,015, 37,577, and 8,653 shares vesting respectively.
• Following the vesting, Mr. Blackley sold 24,823 shares on December 2, 2024, at a weighted average price of $18.07 per share.
• He also sold an additional 456 shares on the same day at a weighted average price of $18.48 per share.
• These sales were executed to cover tax obligations related to the vesting of the restricted stock units.
• After these transactions, Mr. Blackley directly owns 881,841 shares of Class A common stock.

Sentiment

Score: 5

Explanation: The document reflects routine insider transactions, which are neither positive nor negative for the company's overall outlook. The sales are related to tax obligations and do not indicate a change in the executive's confidence in the company.

Industry Context

This is a routine disclosure of insider transactions, which is common for publicly traded companies. It reflects the standard practice of executives selling shares to cover tax obligations after stock options or restricted stock units vest.

Comparison to Industry Standards

• The sale of shares by a CFO after vesting is a common practice across publicly traded companies, including those in the healthcare and insurance sectors.
• Similar transactions are regularly reported by executives at companies like UnitedHealth Group (UNH), Anthem (ANTM), and Cigna (CI), where stock-based compensation is a significant part of executive pay.
• The timing and volume of these sales are often influenced by personal financial planning and tax considerations, aligning with industry norms for executive compensation management.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on shareholders, as they are routine and related to executive compensation.
• The sales are not indicative of any change in the company's performance or outlook.

Key Dates

Keywords

Oscar Health, Richard Blackley, Class A Common Stock, Restricted Stock Units, SEC Form 4, Insider Trading, Stock Sale, Vesting